000 | 02075cam a2200349 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
005 | 20250223030537.0 | ||
008 | 120110s2011 ua dh f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aDeposite | ||
097 | _aPh.D | ||
099 | _aCai01.11.15.Ph.D.2011.Yo.C | ||
100 | 0 | _aYomna Ali Bayoumi | |
245 | 1 | 0 |
_aComparative study of clinical features and sonographic criteria with monitoring of ovulation induction with clomiphene citrate between obese and non obese polycstic ovarian disease patients / _cYomna Ali Bayoumi ; Supervised Ayman Abdelhalim Marzouk , Mostafa Mohammed Abdelbar , Samar Aly Marzouk |
246 | 1 | 5 | _aدراسة مقارنة بين الاعراض السريرية والخواص بالموجات الصوتية ومتابعة تنشيط التبويض بالكلومفين سيترات لدى السيدات النحفاء والمصابين بمرض السمنة مع عرض تكيس المبايض التعددى |
260 |
_aCairo : _bYomna Ali Bayoumi , _c2011 |
||
300 |
_a188 P. : _bcharts , facsimiles ; _c25cm |
||
502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Gynecology and Obstetrics | ||
520 | _aPolycystic ovarian disease is the most common endocrinopathy in women of reproductive age affecting 5- 10% of population and is the leading cause of female infertility . Obesity may constitute a major impediment of successful fertility treatment in women with polycystic ovarian syndrome . Lean Polycystic patients better respond to ovulation induction with clomiphene citrate compared to obese Polycystic patients | ||
530 | _aIssued also as CD | ||
653 | 4 | _aObese | |
653 | 4 | _aOvulation induction | |
653 | 4 | _aPolycystic ovarian syndrome | |
700 | 0 |
_aAyman Abdelhalim Marzouk , _eSupervisor |
|
700 | 0 |
_aMostafa Mohammed Abdelbar , _eSupervisor |
|
700 | 0 |
_aSamar Aly Marzouk , _eSupervisor |
|
856 | _uhttp://172.23.153.220/th.pdf | ||
905 |
_aNazla _eRevisor |
||
905 |
_aSoheir _eCataloger |
||
942 |
_2ddc _cTH |
||
999 |
_c36892 _d36892 |